Missing gastric cancer in dyspepsia

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 7, 2005, Pages 813-820

  Schmidt, N ^a   Peitz, U ^a   Lippert, H ^a   Malfertheiner, P ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER SCREENING; CANCER STAGING; DYSPEPSIA; EARLY DIAGNOSIS; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSTIC ERRORS; DYSPEPSIA; FEMALE; GASTROSCOPY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS;

EID: 16444364965     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02425.x     Document Type: Article

References (40)

1. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. Version 1.0. IARC Cancer Base No. 5. Lyon. France: IARC Press. 2001. Available at: http://ivww-dep.iarc.fr/globocan/ globocan.htm. Last accessed, 22 June 2004.
2. Ferlay J, Bray F, Sankila R, et al. EUCAN: Cancer Incidence. Mortality and Prevalence in the European Union 1997. Version 4.0. IARC Cancer Base No. 4. Lyon. France: IARC Press, 1999. Available at: http://www-dep.iarc.fr/eucan/ eucan.htm. Last accessed. 22 June 2004.
3. Everett SM, Axon AT. Early gastric cancer in Europe. Gut 1997; 41: 142-50.
4. Alexander HR, Kelsen DG, Tepper JC. Cancer of the stomach. In: DeVita, VT, Hellman, S, Rosenberg, SA. eds. Cancer: Principles and Practice of Oncology. New York. USA: Lippincott-Raven, 1997: 1021-54.
5. Noguchi Y, Yoshikawa T, Tsuburaya A, et al. Is gastric carcinoma different between Japan and the United States? Cancer 2000; 89: 2237-46.
6. Roukos DH. Current status and future perspectives in gastric cancer management. Cancer Treat Rev 2000; 26: 243-55.
7. Wanebo HJ, Kennedy BJ, Chmiel J, et al. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 1993; 218: 583-92.
8. American Gastroenterological Association. AGA medical position statement: evaluation of dyspepsia. Gastroenterology 1998; 114: 579-81.
9. Talley NJ, Silverstein MD, Agreus L, et al. AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology 1998; 114: 582-95.
10. Malfertheiner P. Current concepts in dyspepsia: a world perspective. Eur J Gastroenterol Hepatol 1999; 11 (Suppl. 1): S25-9.
11. Talley NJ. Therapeutic options in nonulcer dyspepsia. J Clin Gastroenterol 2001; 32: 286-93.
12. Malfertheiner P, Megraud F, O'Morain C, et al. European Helicobacter pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection. The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167-80.
13. Gillen D, McColl KE. Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55 (Letter)? Am J Gastroenterol 1999; 94: 2329-30.
14. Gillen D, McColl KE. Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55? Am J Gastroenterol 1999; 94: 75-9.
15. Christie J, Shepherd NA, Codling BW, et al. Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia. Gut 1997; 41: 513-7.
16. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997; 277: 925-6.
17. Sobin LH, Wittekind C. TNM Classification of Malignant Tumors, 5th edn. New York, USA; Willey-Liss, 1997.
18. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
19. Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995; 333: 32-41.
20. Hermanek P. The superiority of the new International Union Against Cancer and American Joint Committee on Cancer TNM staging of gastric carcinoma (Editorial). Cancer 2000; 88: 1763-5.
21. Siewert JR, Bottcher K, Stein HJ, et al. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998; 228: 449-61.
22. Murakami T. Pathomorphological diagnosis. Definition and gross classification of early gastric cancer. Gann Monogr Cancer Res 1971; 11: 53-5.
23. Shiomi M, Kamisako T, Yutani I, et al. Two cases of histopathologically advanced (stage IV) early gastric cancers. Tumori 2001; 87: 191-5.
24. Shchepotin IB, Chorny VA, Nauta RJ, et al. Extended surgical resection in T4 gastric cancer. Am J Surg 1998; 175: 123-6.
25. Bruckner HW, Kondo T, Kondo K. Neoplasms of the stomach. In: Holland, JF, Bast, RC, Morton, DL, Frei, E, Kufe, DW, Weichselbaum, RR, eds. Cancer Medicine. New York, USA: American Cancer Society, 1997: 1879-922.
26. Talley NJ, Axon A, Bytzer P, et al. Management of uninvestigated and functional dyspepsia: a working party report for the World Congresses of Gastroenterology 1998. Aliment Pharmacol Ther 1999; 13: 1135-48.
27. 7 Van Zanten SJ. Can the age limit for endoscopy be increased in dyspepsia patients who do not have alarm symptoms (Editorial)? Am J Gastroenterol 1999; 94: 9-11.
28. Sano T, Sasako M. Green tea and gastric cancer (Editorial). N Engl J Med 2001; 344: 675-6.
29. Patel P, Khulusi S, Mendall MA, et al. Prospective screening of dyspeptic patients by Helicobacter pylori serology. Lancet 1995; 346: 1315-8.
30. Breslin NP, Thomson AB, Bailey RJ, et al. Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia. Gut 2000; 46: 93-7.
31. Adang RP, Vismans JF, Talmon JL, et al. Appropriateness of indications for diagnostic upper gastrointestinal endoscopy: association with relevant endoscopic disease. Gastrointest Endosc 1995; 42: 390-7.
32. Sasamori N, Hinohara S, Tamura M, et al. Results of screening for cancer in Japanese in the prime of life - an analysis of nationwide MHTS and human dry dock statistics. Preventive Medicine Committee of the Japan Hospital Association. Jpn Hosp 1999; 18: 71-8.
33. Tsukuma H, Mishima T, Oshima A. Prospective study of 'early' gastric cancer. Int J Cancer 1983; 31: 421-6.
34. Sasako M. What is reasonable treatment for gastric adenocarcinoma? J Gastroenterol 2000; 35 (Suppl. 12): 116-20.
35. Muta Y, Baba Y, Nishiyama M, et al. Characteristics and progress of treatment for gastric cancers detected by mass screening. Can To Kagaku Ryoho 1998; 25: 1505-13 (in Japanese).
36. National Cancer Institute. Screening for Gastric Cancer. Bethesda: National Cancer Institute. 2002. Available at: http://www.cancer.gov/ CancerInformation/doc_pdq.aspx? version=1&summaryid=208_04880. Last accessed. 22 June 2004.
37. Eckardt VF, Giessler W, Kanzler G, et al. Clinical and morphological characteristics of early gastric cancer. A case-control study. Gastroenterology 1990; 98: 708-14.
38. Green PH, O'Toole KM, Slonim D, et al. Increasing incidence and excellent survival of patients with early gastric cancer: experience in a United States medical center. Am J Med 1988; 85: 658-61.
39. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
40. Wong BC, Lam SK, Wong WM, et al. China Gastric Cancer Study Group. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-94.